Get 30% off on all global market reports with code ONLINE30 – stay updated on tariff changes, macroeconomic trends, and more!
Outpatient Oncology Infusion Industry Expansion: How the Market Size Has Grown Over the Last 5 Years?
The market size of outpatient oncology infusion has substantially increased over the past few years. A growth from $12.99 billion in 2024 to $14.02 billion in 2025 is anticipated, with a compound annual growth rate (CAGR) of 7.9%. The expansion during the historic period can be credited to increasing incidences of cancer, growth in outpatient centers, patients’ inclination towards homely environments, enhanced insurance coverage, transition from inpatient to outpatient treatment, and an uplift in survival rates.
The market size of outpatient oncology infusion is projected to experience robust growth in the forthcoming years. It is predicted to reach $18.81 billion by 2029, boasting a compound annual growth rate (CAGR) of 7.6%. The impetus for growth during the forecast period can be linked to factors such as an aging population, increasing demand for individualized medicine, widespread usage of biosimilars, focus on cost reduction, value-driven repayment models, and a shortage of workforce. Key trends during the forecast period encompass innovations in infusion devices, the incorporation of telehealth services, technology-powered remote patient monitoring, headway in personalized medicine, and progress in targeted therapies.
Claim Your Free Sample Report:
http://www.thebusinessresearchcompany.com/sample….p;type=smp
What Growth Drivers Are Responsible for Accelerating Outpatient Oncology Infusion Market Growth?
The escalation in cancer occurrences is predicted to boost the development of the outpatient oncology infusion market in the future. Cancer, characterized by the rampant multiplication of irregular cells that can infiltrate nearby tissues and transfer to other body parts, is becoming more common, primarily due to the internatinal aging population. This is because the chance of getting cancer tends to increase considerably with age.
Outpatient oncology infusion facilitates the administration of cancer treatments, like chemotherapy, immunotherapy, or specific therapy, in a clinical environment, without the requirement for hospitalization. This allows patients to continue with their regular schedules while receiving necessary care. For example, estimations from Macmillan Cancer Support (a UK-operated charity providing tangible, emotional, and financial aid to those battling cancer) suggest that, as of April 2024, the number of cancer patients in the UK is set to rise from its current 3 million, to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. This increase in cancer occurrences, thus, fuels the expansion of the outpatient oncology infusion market.
Performance of Leading Segments in the Outpatient Oncology Infusion Global Market
The outpatient oncology infusion market covered in this report is segmented –
1) By Product: Infusion Pumps, Intravenous Sets, Intravenous Cannulas, Needleless Connectors
2) By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy
3) By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer, Other Cancers
4) By End-User: Hospitals, Outpatient Clinics, Home Care Settings
Subsegments:
1) By Infusion Pumps: Volumetric Infusion Pumps, Syringe Infusion Pumps, Elastomeric Infusion Pumps, Ambulatory Infusion Pumps, Smart Infusion Pumps
2) By Intravenous Sets: Vented IV Sets, Non-Vented IV Sets, Gravity IV Sets, Pump-Compatible IV Sets, Filtered IV Sets
3) By Intravenous Cannulas: Peripheral IV Cannulas, Central IV Cannulas, Winged IV Cannulas (Butterfly), Closed IV Cannulas, Safety IV Cannulas
4) By Needleless Connectors: Positive Displacement Connectors, Negative Displacement Connectors, Neutral Displacement Connectors, Closed System Transfer Devices (CSTDs), Anti-Reflux Connectors
Access the Full Report Today:
http://www.thebusinessresearchcompany.com/report/…ket-report
What are the upcoming Trends Poised to Transform the Future of the Outpatient Oncology Infusion Market?
Leading enterprises in the outpatient oncology infusion market are turning their attention towards cutting-edge product development, such as syringe infusion pumps. These innovative products aim to augment infusion precision, elevate patient safety standards, and modernize medication delivery by using updated software and dose error minimization systems. In essence, a syringe infusion pump or syringe driver is an automated gadget well-equipped to meticulously manage fluid flow by mechanically fine-tuning the plunger of a syringe. As an illustration, in August 2022, Baxter International Inc., an American healthcare firm known for specializing in surgical and intravenous infusion technologies, attained clearance from the U.S. Food and Drug Administration (FDA) for their Novum IQ Syringe Infusion Pump (SYR) integrated with Dose IQ Safety Software. The system leverages Baxter’s futuristic, web-based Dose IQ platform, outfitted with a customizable drug library and a dose error reduction feature. By providing central access to up-to-date medication knowledge in real-time, this system aims to assist clinicians and healthcare institutions. Primarily designed for outpatient healthcare scenarios, such as outpatient oncology infusion circumstances, it ensures precise, programmable infusions of therapeutic drugs in an array of clinical care contexts.
What Are the Regional Hotspots for Outpatient Oncology Infusion Market Growth?
North America was the largest region in the outpatient oncology infusion market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the outpatient oncology infusion market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get a Customized Version of the Report:
http://www.thebusinessresearchcompany.com/customi…p;type=smp
Which Companies Hold the Largest Market Share in the Outpatient Oncology Infusion Industry?
Major companies operating in the outpatient oncology infusion market are Medtronic plc, Becton Dickinson and Company, Baxter International Inc., Fresenius Kabi AG, Terumo Corporation, Nipro Corporation, Smiths Medical Inc., ICU Medical Inc., B. Braun Melsungen AG, InfuSystem Holdings Inc., BPL Medical Technologies Private Limited, Angiplast Private Limited, Bio-Med Healthcare Products Private Limited, Lars Medicare Private Limited, Micrel Medical Devices S.A., AKAS Infusions Private Limited, Mais India Medical Devices Private Limited, Wellead Medical Co. Ltd., AdvaCare Pharma USA LLC, Polymed Medical Devices Private Limited.
Access the Complete Report:
http://www.thebusinessresearchcompany.com/purchas…x?id=25861
How Our Market Research Reports Help Maximize ROI Across Industries:
* Identify High-Growth Opportunities: Pinpoint emerging trends, untapped segments, and regional hotspots that align with your strategic goals.
* Reduce Investment Risk: Make data-driven decisions with confidence by understanding market dynamics, key drivers, and competitive threats.
* Optimize Strategic Planning: Align your product development, marketing, and expansion plans with industry forecasts and customer behaviour insights.
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at This email address is being protected from spambots. You need JavaScript enabled to view it.
News From
The Business Research Company …
Category: Industry Reports & Market Analysis Profile: The Business Research Company is a leading market research and consulting services provider. It offers over 9,500 market reports across 27 industries in 60+ geographies, providing detailed insights and forecasts. Its customised research solutions support companies in making critical decisions, while its continuous research service enhances organizational capabilities. The flagship Global Market Model database provides comprehensive market intelligence with 1,500,000 datasets covering 8,000+ mark …
This email address is being protected from spambots. You need JavaScript enabled to view it.
